SlideShare a Scribd company logo
Cardiac function
test
By : zalak , jemisha , namrta , priyanka ,
kalyani , dipika
Introduction
o Cardiac function tests used to determine
whether there has been any cardiac tissue
damage.
o This tests performed to help diagnose a
cardiac disease.
o Myocardial infarction
o Coronary artery disease
o Atherosclerosis
Cardiac function tests include
1. CK (Creatine kinase)
2. CK-MB
3. LDH (Lactate Dehydrogenase)
4. SGOT
5. Troponin
6. Myoglobin
7. Lipid Profile :
1. Cholesterol
2. Triglyceride
3. HDL-cholesterol
4. LDL-cholesterol
5. VLDL-cholesterol
8. LDL/HDL ratio
9. LDL/Total cholesterol
10. Apolipoprotein – A1
11. Apolipoprotein - B
1. CK (CREATINE KINASE)
Principle:
Method : Increasing Kinetic
Biological reference range :- 25-120 U/L
Clinical Significance:
 CPK ( Creatine phosphokinase ) activity is
increase in
 Brain (CK-BB = 1%)
 Cerebro-vascular stroke
 heart muscle (CK-MB = 5-10%)
 Myocardial infarction
 Acute coroary syndrome
 skeletal muscle. (CK-MM= 85%)
 Crush injury
 Myopathy
 Polymyositis
2. CK-MB
Principle:
 measurement of CK activity in the presence of an
antibody to CK-M monomer.
 This antibody completely inhibits the activity of CK-MM
& half of the activity of CK-MB while not affecting the B
subunit activity of CK-MB &CK-BB.
Method :
• Increasing Kinetic UV method
Biological reference range :-0 - 25 IU/L
Significance:
• CK-MB present only in cardiac tissue
• So…Specific for diagnosis of cardiac
disease
CK-2 & CK-3 in normal subject &
After 24 hours of Myocardial Infarction
Creatine Kinase isoenzymes in blood
3. LDH (lactate dehydrogenase)
Principle:
 Lactate dehydrogenase catalyses the conversion of
pyruvate to lactate.
Lactate dehydrogenase
Lactate + NAD+ ---------------- Pyruvate + NADH + H+
The rate of NADH+ formation is measured by 340nm
filter.
It is direactly propotional to serum LDH activity.
Method :
• IFCC method (Lactate to Pyruvate method )
• Increasing kinetic
Biological reference range :- 70-240 IU/L
Clinical significance :
 RBC
 Malaria
 Sickle cell anemia
 hemolytic disorder
 Liver
 Viral Hepatitis
 Liver malgnancy
 Alcoholic liver disease
 Cardiac tissue
 Myocardial infarction
 Skeletal muscle
 Muscular distrophy
 Crush injury
LDH Iso-enzyme
4. GOT ( AST )
Principle:
L-Aspartate+α Ketoglutarate
GOT(with P5P)
Oxaloacetate + LGlutamate
Oxaloacetate + NADH + H+
MDH
Malate + NAD+
AST = Aspartate Transaminase
GOT = Glutamic Oxalate Transaminase
The rate of NADH to NAD is measured as a decrease in absorbance at 340
nm.
 Method:
 IFCC method with / without Pyridoxal 5 phosphate
(P5P)
 Decrease UV - kinetic
 Biological reference range:
 15 – 45 IU/L
 Clinical significance:
1. Acute hepatocellular damage
2. Myocardial infarction
3. Congestive heart failure.
4. Biliary tract obstruction
5. Cholicyctisis
5. Cardiac Troponin – I &
Cardiac Troponin - T
 The troponin complex consists of 3 components;
 Troponin C(calcium binding)
 Troponin I(actomysin ATPase inhibitary element)
 Troponin T(tropomyosin binding element).
 Measured by
 ELISA or RIA techniques.
 Immunoturbidometry
 Immuno-diffusion method
 Serum level of troponin T increases within 6 hrs of
myocardial infarction.
 Troponin I is released into the blood within 4 hrs after
the onset of cardiac symtoms.
Biological reference range:-
Troponin I : 0.04 – 40 ng/ml.
Troponin T : 0.01 – 25 ng/ml.
Significance:
For diagnosis of myocardial damage.
 Most sensitive
 Specific test
 Early detectable.
 It used mainly in the diagnosis of chest-pain
patients when ECG is normal.
Cardiac Marker
Cardiac Marker
Plasma Enzymes Changes
After Myocardial Infarction
6. myoglobin
 O2 binding protein in skeletal and cardiac muscles
 Released mailnly from skeletal muscle damaged
tissues.
 Its level rises more rapidly than C-troponin and CK-
MB.
Principle:
 RIA (Radio-Immuno Assay )
 ELISA (Enzyme Link Immuno-Sorbant Assay)
 Chemiluminescence.
Biological reference range:-
25 – 72 ng/ml
Significance:
• Major skeletal muscular injury
• Crush injury
• Burns
7. Lipid profile:
1. Total Cholesterol
2. Triglyceride
3. HDL-cholesterol ( High Density Lipoprotein )
4. LDL-cholesterol ( Low Density Lipoprotein )
5. VLDL-cholesterol ( Very Low Density Liporotein )
 Cholesterol
Principle:
 Absorbance of quinoneimine dye is measured at
500nm.
Method:
• Enzymatic method
Biological reference range:-
Less than 199 mg /dL (Normal)
200 – 239 mg/dl (borderline)
More than 240 mg/dl (high)
Clinical significance : -
Increase cholesterol suggestive of increase probability of
following
• Atherosclerosis
• Coronary artery disease
• Ischemic heart disease
• Cerebro-Vascular Stroke
• Hypertension
• Xanthoma
Decrease cholesterol suggestive of increase probability of
following
• Depression
 Triglyceride
Principle:
 Absorption of quinoneimine dye (red color) is
measured at 510nm.
Method :
 GPO – POD Method
 End point method
Biological reference range:-
<150mg/dl
Clinical significance:
• 150 to 400 mg/dl is consider borderline
hypertriglyceridemia.
• More than 400 mg/dl only, increase risk of
pancreatitis
HDL , LDL , VLDL
 HDL(High Density Lipoprotine)
Principle:
 Precipitates of all lipoprotein other than HDL (LDL
& VLDL lipoproteins)
 Precipitation done by
 Dextran Sulfate
 phosphotungsate acid
 Polyethyl glycol
 HDL left in the supernatant is tested using
cholesterol assay.
Method: Precipitation reaction
Biological reference range :- 40-60 mg/dl
HDL less than 40mg/dl means high risk of heart
disease.
Significance:
 HDL transport cholesterol from peripheral tissues
to liver by reverse cholesterol transport.
 HDL also helps in the removal of macrophages
from the arterial walls.
 LDL(Low Density Lipoprotien)
Principle:
 Direct method: (selective precipitation)
 Indirect method: (fridewald equation)
LDL = [Total Cholesterol – HDL] – Plasma TG
(mg/dl)
5
Biological reference range:- 130-160 mg/dl
LDL more than 160mg/dl means high risk of heart
disease.
Significance:
 LDL tarnsport cholesterol from liver to peripheral
cells.
 VLDL(very low density
lipoprotien)
Friedewald’s equation:
VLDL = Triglyceride/5 (mg/dl)
Limitation :
Can not useful in case of TG > 400 mg%
Biological reference range:- 2-30 mg/dl
Ratio of Cholesterol
DETERMINATION OF
APOLIPOPROTIEN- A1 & B
METHOD:- Turbidimetric immunoassays (TIA)
PRINCIPLE:-
 An insoluble TIA is formed by the reaction
between the apo A-I antigen in human serum &
the specific antibody in the antibody reagent. By
using the activactor reagent,maximum exposure
of antigenic sites achieved.
 The turbidity is measured at 340nm.
Biological reference range:-
 Apolipoprotein A:-
 More than 50mg/dl is desirable.
Apolipoprotein B:-
 less than 80mg/dl is desirable.

More Related Content

What's hot

Serum protein electrophpresis
Serum protein electrophpresisSerum protein electrophpresis
Serum protein electrophpresisMusa Khan
 
Lipid profile test
Lipid profile testLipid profile test
Lipid profile testmedicomicro
 
Understanding and Interpreting Serum Protein Electrophoresis
Understanding and Interpreting Serum Protein ElectrophoresisUnderstanding and Interpreting Serum Protein Electrophoresis
Understanding and Interpreting Serum Protein ElectrophoresisFysiMack
 
Estimation of uric acid levels in blood
Estimation of uric acid levels in bloodEstimation of uric acid levels in blood
Estimation of uric acid levels in bloodSanaSamadKhan
 
Serum protein electrophoresis & their clinical importance
Serum protein electrophoresis & their clinical importanceSerum protein electrophoresis & their clinical importance
Serum protein electrophoresis & their clinical importanceDr.M.Prasad Naidu
 
Estimation Glucose in blood
Estimation Glucose in bloodEstimation Glucose in blood
Estimation Glucose in bloodTehmas Ahmad
 
Urine examination , urine, chemical examination
Urine examination , urine, chemical examinationUrine examination , urine, chemical examination
Urine examination , urine, chemical examinationsandeep singh
 
CREATINE PHOSPHOKINASE best slide.pptx
CREATINE PHOSPHOKINASE best slide.pptxCREATINE PHOSPHOKINASE best slide.pptx
CREATINE PHOSPHOKINASE best slide.pptxGunlupeGangmei
 
Kidney function tests
Kidney function testsKidney function tests
Kidney function testsRamesh Gupta
 

What's hot (20)

Serum protein electrophpresis
Serum protein electrophpresisSerum protein electrophpresis
Serum protein electrophpresis
 
phosphorus estimation
phosphorus estimationphosphorus estimation
phosphorus estimation
 
Lipid profile test
Lipid profile testLipid profile test
Lipid profile test
 
Liver function tests 2020
Liver function tests 2020Liver function tests 2020
Liver function tests 2020
 
Understanding and Interpreting Serum Protein Electrophoresis
Understanding and Interpreting Serum Protein ElectrophoresisUnderstanding and Interpreting Serum Protein Electrophoresis
Understanding and Interpreting Serum Protein Electrophoresis
 
Urine preservative
Urine preservative Urine preservative
Urine preservative
 
Estimation of uric acid
Estimation of uric acidEstimation of uric acid
Estimation of uric acid
 
LIVER FUNCTIONS TESTS -1-
LIVER FUNCTIONS TESTS -1-LIVER FUNCTIONS TESTS -1-
LIVER FUNCTIONS TESTS -1-
 
Estimation of uric acid levels in blood
Estimation of uric acid levels in bloodEstimation of uric acid levels in blood
Estimation of uric acid levels in blood
 
Dry chemistry
Dry chemistryDry chemistry
Dry chemistry
 
Bilirubin estimation
Bilirubin estimationBilirubin estimation
Bilirubin estimation
 
Serum protein electrophoresis & their clinical importance
Serum protein electrophoresis & their clinical importanceSerum protein electrophoresis & their clinical importance
Serum protein electrophoresis & their clinical importance
 
urea-Chemical Pathology
urea-Chemical Pathologyurea-Chemical Pathology
urea-Chemical Pathology
 
Hb a1c
Hb a1cHb a1c
Hb a1c
 
Estimation of serum urea
Estimation of serum ureaEstimation of serum urea
Estimation of serum urea
 
Estimation Glucose in blood
Estimation Glucose in bloodEstimation Glucose in blood
Estimation Glucose in blood
 
Urine examination , urine, chemical examination
Urine examination , urine, chemical examinationUrine examination , urine, chemical examination
Urine examination , urine, chemical examination
 
CREATINE PHOSPHOKINASE best slide.pptx
CREATINE PHOSPHOKINASE best slide.pptxCREATINE PHOSPHOKINASE best slide.pptx
CREATINE PHOSPHOKINASE best slide.pptx
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Kidney function tests
Kidney function testsKidney function tests
Kidney function tests
 

Similar to cardiac_function_test_2018.ppt

lipid profile & Ix of MI.ppt
lipid profile & Ix of MI.pptlipid profile & Ix of MI.ppt
lipid profile & Ix of MI.pptDrRhutaShah1
 
lipids & dyslipoproteinemia
 lipids & dyslipoproteinemia lipids & dyslipoproteinemia
lipids & dyslipoproteinemiaJessabeth Aluba
 
Assessment of LDL-Cholesterol: Calculated vis-A-vis Direct Method
Assessment of LDL-Cholesterol: Calculated vis-A-vis Direct MethodAssessment of LDL-Cholesterol: Calculated vis-A-vis Direct Method
Assessment of LDL-Cholesterol: Calculated vis-A-vis Direct MethodAdeniji Adekoga
 
Diabetic Dyslipidemia - A True CV risk
Diabetic Dyslipidemia - A True CV riskDiabetic Dyslipidemia - A True CV risk
Diabetic Dyslipidemia - A True CV riskUsama Ragab
 
LABORATORY STUDIES OF CARDIAC DISORDERS
LABORATORY STUDIES OF CARDIAC DISORDERSLABORATORY STUDIES OF CARDIAC DISORDERS
LABORATORY STUDIES OF CARDIAC DISORDERSPoojaMhalatkar
 
Biochemistry of blood in relation to cardio pulmonary function
Biochemistry of blood in relation to cardio pulmonary functionBiochemistry of blood in relation to cardio pulmonary function
Biochemistry of blood in relation to cardio pulmonary functionPrincy Francis M
 
Cholestrol &amp; its significance
Cholestrol &amp; its significanceCholestrol &amp; its significance
Cholestrol &amp; its significancemelbia shine
 
Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...
Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...
Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...vaibhavyawalkar
 
Nrcar dyslipidaemia poster_web
Nrcar dyslipidaemia poster_webNrcar dyslipidaemia poster_web
Nrcar dyslipidaemia poster_webElsa von Licy
 
Nrcar interactive dyslipidaemia_poster
Nrcar interactive dyslipidaemia_posterNrcar interactive dyslipidaemia_poster
Nrcar interactive dyslipidaemia_posterElsa von Licy
 
Ch 9 Lipid2.ppt
Ch 9 Lipid2.pptCh 9 Lipid2.ppt
Ch 9 Lipid2.pptcarlmanaay
 
Raising HDL with drugs - does it work?
Raising HDL with drugs - does it work?Raising HDL with drugs - does it work?
Raising HDL with drugs - does it work?My Healthy Waist
 
Estimation of Serum Cholesterol and HDL
Estimation of Serum Cholesterol and HDLEstimation of Serum Cholesterol and HDL
Estimation of Serum Cholesterol and HDLASHIKH SEETHY
 
LIPID PROFILE_041210.pptx
LIPID PROFILE_041210.pptxLIPID PROFILE_041210.pptx
LIPID PROFILE_041210.pptxsandip44647
 
Cardiac profile tests(biochemical )
Cardiac profile tests(biochemical )Cardiac profile tests(biochemical )
Cardiac profile tests(biochemical )rohini sane
 

Similar to cardiac_function_test_2018.ppt (20)

Cardiac function tests.pptx
Cardiac function tests.pptxCardiac function tests.pptx
Cardiac function tests.pptx
 
lipid profile & Ix of MI.ppt
lipid profile & Ix of MI.pptlipid profile & Ix of MI.ppt
lipid profile & Ix of MI.ppt
 
lipids & dyslipoproteinemia
 lipids & dyslipoproteinemia lipids & dyslipoproteinemia
lipids & dyslipoproteinemia
 
Assessment of LDL-Cholesterol: Calculated vis-A-vis Direct Method
Assessment of LDL-Cholesterol: Calculated vis-A-vis Direct MethodAssessment of LDL-Cholesterol: Calculated vis-A-vis Direct Method
Assessment of LDL-Cholesterol: Calculated vis-A-vis Direct Method
 
HDL
HDL HDL
HDL
 
Diabetic Dyslipidemia - A True CV risk
Diabetic Dyslipidemia - A True CV riskDiabetic Dyslipidemia - A True CV risk
Diabetic Dyslipidemia - A True CV risk
 
LABORATORY STUDIES OF CARDIAC DISORDERS
LABORATORY STUDIES OF CARDIAC DISORDERSLABORATORY STUDIES OF CARDIAC DISORDERS
LABORATORY STUDIES OF CARDIAC DISORDERS
 
Lipids made simple
Lipids made simple Lipids made simple
Lipids made simple
 
Biochemistry of blood in relation to cardio pulmonary function
Biochemistry of blood in relation to cardio pulmonary functionBiochemistry of blood in relation to cardio pulmonary function
Biochemistry of blood in relation to cardio pulmonary function
 
Cholestrol &amp; its significance
Cholestrol &amp; its significanceCholestrol &amp; its significance
Cholestrol &amp; its significance
 
Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...
Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...
Diabetic dyslipidemia and residual risk by Dr. Vaibhav Yawalkar MD DM Cardiol...
 
Nrcar dyslipidaemia poster_web
Nrcar dyslipidaemia poster_webNrcar dyslipidaemia poster_web
Nrcar dyslipidaemia poster_web
 
Nrcar interactive dyslipidaemia_poster
Nrcar interactive dyslipidaemia_posterNrcar interactive dyslipidaemia_poster
Nrcar interactive dyslipidaemia_poster
 
Ch 9 Lipid2.ppt
Ch 9 Lipid2.pptCh 9 Lipid2.ppt
Ch 9 Lipid2.ppt
 
Raising HDL with drugs - does it work?
Raising HDL with drugs - does it work?Raising HDL with drugs - does it work?
Raising HDL with drugs - does it work?
 
Estimation of Serum Cholesterol and HDL
Estimation of Serum Cholesterol and HDLEstimation of Serum Cholesterol and HDL
Estimation of Serum Cholesterol and HDL
 
Lipids in the blood
Lipids in the bloodLipids in the blood
Lipids in the blood
 
CVS lipoprotein metabolism, .pptx
CVS lipoprotein metabolism, .pptxCVS lipoprotein metabolism, .pptx
CVS lipoprotein metabolism, .pptx
 
LIPID PROFILE_041210.pptx
LIPID PROFILE_041210.pptxLIPID PROFILE_041210.pptx
LIPID PROFILE_041210.pptx
 
Cardiac profile tests(biochemical )
Cardiac profile tests(biochemical )Cardiac profile tests(biochemical )
Cardiac profile tests(biochemical )
 

More from ssuser668f10

Urine and Stool analysis.ppt urine and stool analysis
Urine and Stool analysis.ppt urine and stool analysis Urine and Stool analysis.ppt urine and stool analysis
Urine and Stool analysis.ppt urine and stool analysis ssuser668f10
 
Glossary_ST_NAR_26_A.pdf medical
Glossary_ST_NAR_26_A.pdf medical Glossary_ST_NAR_26_A.pdf medical
Glossary_ST_NAR_26_A.pdf medical ssuser668f10
 
Blood cell morphology.ppt
Blood cell morphology.pptBlood cell morphology.ppt
Blood cell morphology.pptssuser668f10
 
Practical 40 biochemical test microbiology.pdf
Practical 40 biochemical test microbiology.pdfPractical 40 biochemical test microbiology.pdf
Practical 40 biochemical test microbiology.pdfssuser668f10
 
5 Leukopoiesis (1).pdf
5                     Leukopoiesis (1).pdf5                     Leukopoiesis (1).pdf
5 Leukopoiesis (1).pdfssuser668f10
 
biochemicalreactionsnew-190412162327.pdf
biochemicalreactionsnew-190412162327.pdfbiochemicalreactionsnew-190412162327.pdf
biochemicalreactionsnew-190412162327.pdfssuser668f10
 
Type of Tumors بلال العميسي( مختبرات طبية).pptx
Type of Tumors بلال العميسي( مختبرات طبية).pptxType of Tumors بلال العميسي( مختبرات طبية).pptx
Type of Tumors بلال العميسي( مختبرات طبية).pptxssuser668f10
 
الاحماض النوويه1.ppt
الاحماض النوويه1.pptالاحماض النوويه1.ppt
الاحماض النوويه1.pptssuser668f10
 
Clinical enzymology.ppt
Clinical enzymology.pptClinical enzymology.ppt
Clinical enzymology.pptssuser668f10
 
جميل الغيثي.en.ar.pptx
جميل الغيثي.en.ar.pptxجميل الغيثي.en.ar.pptx
جميل الغيثي.en.ar.pptxssuser668f10
 
بكتيريا.en.ar.pptx
بكتيريا.en.ar.pptxبكتيريا.en.ar.pptx
بكتيريا.en.ar.pptxssuser668f10
 
Neutralization--TV (1).pptx
Neutralization--TV (1).pptxNeutralization--TV (1).pptx
Neutralization--TV (1).pptxssuser668f10
 
EpidemiologyOverview.ppt
EpidemiologyOverview.pptEpidemiologyOverview.ppt
EpidemiologyOverview.pptssuser668f10
 
ANTI COAGULANT (2).pptx
ANTI COAGULANT (2).pptxANTI COAGULANT (2).pptx
ANTI COAGULANT (2).pptxssuser668f10
 
Carbohydrates Metabolism - Copy.pptx
Carbohydrates Metabolism - Copy.pptxCarbohydrates Metabolism - Copy.pptx
Carbohydrates Metabolism - Copy.pptxssuser668f10
 
safety_chem_course_en.en.ar.pdf
safety_chem_course_en.en.ar.pdfsafety_chem_course_en.en.ar.pdf
safety_chem_course_en.en.ar.pdfssuser668f10
 

More from ssuser668f10 (20)

Urine and Stool analysis.ppt urine and stool analysis
Urine and Stool analysis.ppt urine and stool analysis Urine and Stool analysis.ppt urine and stool analysis
Urine and Stool analysis.ppt urine and stool analysis
 
Glossary_ST_NAR_26_A.pdf medical
Glossary_ST_NAR_26_A.pdf medical Glossary_ST_NAR_26_A.pdf medical
Glossary_ST_NAR_26_A.pdf medical
 
Blood cell morphology.ppt
Blood cell morphology.pptBlood cell morphology.ppt
Blood cell morphology.ppt
 
Practical 40 biochemical test microbiology.pdf
Practical 40 biochemical test microbiology.pdfPractical 40 biochemical test microbiology.pdf
Practical 40 biochemical test microbiology.pdf
 
5 Leukopoiesis (1).pdf
5                     Leukopoiesis (1).pdf5                     Leukopoiesis (1).pdf
5 Leukopoiesis (1).pdf
 
1-1.pdf
1-1.pdf1-1.pdf
1-1.pdf
 
biochemicalreactionsnew-190412162327.pdf
biochemicalreactionsnew-190412162327.pdfbiochemicalreactionsnew-190412162327.pdf
biochemicalreactionsnew-190412162327.pdf
 
Type of Tumors بلال العميسي( مختبرات طبية).pptx
Type of Tumors بلال العميسي( مختبرات طبية).pptxType of Tumors بلال العميسي( مختبرات طبية).pptx
Type of Tumors بلال العميسي( مختبرات طبية).pptx
 
الاحماض النوويه1.ppt
الاحماض النوويه1.pptالاحماض النوويه1.ppt
الاحماض النوويه1.ppt
 
ASO test.ppt
ASO test.pptASO test.ppt
ASO test.ppt
 
Clinical enzymology.ppt
Clinical enzymology.pptClinical enzymology.ppt
Clinical enzymology.ppt
 
جميل الغيثي.en.ar.pptx
جميل الغيثي.en.ar.pptxجميل الغيثي.en.ar.pptx
جميل الغيثي.en.ar.pptx
 
بكتيريا.en.ar.pptx
بكتيريا.en.ar.pptxبكتيريا.en.ar.pptx
بكتيريا.en.ar.pptx
 
Neutralization--TV (1).pptx
Neutralization--TV (1).pptxNeutralization--TV (1).pptx
Neutralization--TV (1).pptx
 
b.coli
b.colib.coli
b.coli
 
EpidemiologyOverview.ppt
EpidemiologyOverview.pptEpidemiologyOverview.ppt
EpidemiologyOverview.ppt
 
ANTI COAGULANT (2).pptx
ANTI COAGULANT (2).pptxANTI COAGULANT (2).pptx
ANTI COAGULANT (2).pptx
 
Carbohydrates Metabolism - Copy.pptx
Carbohydrates Metabolism - Copy.pptxCarbohydrates Metabolism - Copy.pptx
Carbohydrates Metabolism - Copy.pptx
 
1584610537.pptx
1584610537.pptx1584610537.pptx
1584610537.pptx
 
safety_chem_course_en.en.ar.pdf
safety_chem_course_en.en.ar.pdfsafety_chem_course_en.en.ar.pdf
safety_chem_course_en.en.ar.pdf
 

Recently uploaded

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptxNose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptxDr. Rabia Inam Gandapore
 
What is 5 steps for dental health care ?
What is 5 steps for dental health care ?What is 5 steps for dental health care ?
What is 5 steps for dental health care ?Bayview Village Dental
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptMangaiarkkarasi
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfSachin Sharma
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health CareASKatoch1
 
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed EdgeUnlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edgerenewed edge
 
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxUrinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxAnushriSrivastav
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisonersAhmed Elmi
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationBeshedaWedajo
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyIris Thiele Isip-Tan
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
 
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...aunty1x2
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1roti bank
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxAnushriSrivastav
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEranishasharma67
 

Recently uploaded (20)

Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptxNose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
Nose-Nasal Cavity & Paranasal Sinuses BY Dr.Rabia Inam Gandapore.pptx
 
What is 5 steps for dental health care ?
What is 5 steps for dental health care ?What is 5 steps for dental health care ?
What is 5 steps for dental health care ?
 
Secret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage LondonSecret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage London
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdfCHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
CHAPTER- 1 SEMESTER - V NATIONAL HEALTH PROGRAMME RELATED TO CHILD.pdf
 
Integrated Mother and Neonate Childwood Illness Health Care
Integrated Mother and Neonate Childwood Illness  Health CareIntegrated Mother and Neonate Childwood Illness  Health Care
Integrated Mother and Neonate Childwood Illness Health Care
 
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed EdgeUnlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
Unlocking the Benefits of Cognitive Behavioural Therapy (CBT) with Renewed Edge
 
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxUrinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 

cardiac_function_test_2018.ppt

  • 1. Cardiac function test By : zalak , jemisha , namrta , priyanka , kalyani , dipika
  • 2. Introduction o Cardiac function tests used to determine whether there has been any cardiac tissue damage. o This tests performed to help diagnose a cardiac disease. o Myocardial infarction o Coronary artery disease o Atherosclerosis
  • 3. Cardiac function tests include 1. CK (Creatine kinase) 2. CK-MB 3. LDH (Lactate Dehydrogenase) 4. SGOT 5. Troponin 6. Myoglobin 7. Lipid Profile : 1. Cholesterol 2. Triglyceride 3. HDL-cholesterol 4. LDL-cholesterol 5. VLDL-cholesterol 8. LDL/HDL ratio 9. LDL/Total cholesterol 10. Apolipoprotein – A1 11. Apolipoprotein - B
  • 4. 1. CK (CREATINE KINASE) Principle:
  • 5. Method : Increasing Kinetic Biological reference range :- 25-120 U/L Clinical Significance:  CPK ( Creatine phosphokinase ) activity is increase in  Brain (CK-BB = 1%)  Cerebro-vascular stroke  heart muscle (CK-MB = 5-10%)  Myocardial infarction  Acute coroary syndrome  skeletal muscle. (CK-MM= 85%)  Crush injury  Myopathy  Polymyositis
  • 6. 2. CK-MB Principle:  measurement of CK activity in the presence of an antibody to CK-M monomer.  This antibody completely inhibits the activity of CK-MM & half of the activity of CK-MB while not affecting the B subunit activity of CK-MB &CK-BB. Method : • Increasing Kinetic UV method
  • 7. Biological reference range :-0 - 25 IU/L Significance: • CK-MB present only in cardiac tissue • So…Specific for diagnosis of cardiac disease
  • 8.
  • 9. CK-2 & CK-3 in normal subject & After 24 hours of Myocardial Infarction Creatine Kinase isoenzymes in blood
  • 10. 3. LDH (lactate dehydrogenase) Principle:  Lactate dehydrogenase catalyses the conversion of pyruvate to lactate. Lactate dehydrogenase Lactate + NAD+ ---------------- Pyruvate + NADH + H+ The rate of NADH+ formation is measured by 340nm filter. It is direactly propotional to serum LDH activity.
  • 11. Method : • IFCC method (Lactate to Pyruvate method ) • Increasing kinetic Biological reference range :- 70-240 IU/L Clinical significance :  RBC  Malaria  Sickle cell anemia  hemolytic disorder  Liver  Viral Hepatitis  Liver malgnancy  Alcoholic liver disease  Cardiac tissue  Myocardial infarction  Skeletal muscle  Muscular distrophy  Crush injury
  • 13. 4. GOT ( AST ) Principle: L-Aspartate+α Ketoglutarate GOT(with P5P) Oxaloacetate + LGlutamate Oxaloacetate + NADH + H+ MDH Malate + NAD+ AST = Aspartate Transaminase GOT = Glutamic Oxalate Transaminase The rate of NADH to NAD is measured as a decrease in absorbance at 340 nm.  Method:  IFCC method with / without Pyridoxal 5 phosphate (P5P)  Decrease UV - kinetic
  • 14.  Biological reference range:  15 – 45 IU/L  Clinical significance: 1. Acute hepatocellular damage 2. Myocardial infarction 3. Congestive heart failure. 4. Biliary tract obstruction 5. Cholicyctisis
  • 15. 5. Cardiac Troponin – I & Cardiac Troponin - T  The troponin complex consists of 3 components;  Troponin C(calcium binding)  Troponin I(actomysin ATPase inhibitary element)  Troponin T(tropomyosin binding element).  Measured by  ELISA or RIA techniques.  Immunoturbidometry  Immuno-diffusion method  Serum level of troponin T increases within 6 hrs of myocardial infarction.  Troponin I is released into the blood within 4 hrs after the onset of cardiac symtoms.
  • 16. Biological reference range:- Troponin I : 0.04 – 40 ng/ml. Troponin T : 0.01 – 25 ng/ml. Significance: For diagnosis of myocardial damage.  Most sensitive  Specific test  Early detectable.  It used mainly in the diagnosis of chest-pain patients when ECG is normal.
  • 18. Cardiac Marker Plasma Enzymes Changes After Myocardial Infarction
  • 19. 6. myoglobin  O2 binding protein in skeletal and cardiac muscles  Released mailnly from skeletal muscle damaged tissues.  Its level rises more rapidly than C-troponin and CK- MB. Principle:  RIA (Radio-Immuno Assay )  ELISA (Enzyme Link Immuno-Sorbant Assay)  Chemiluminescence.
  • 20. Biological reference range:- 25 – 72 ng/ml Significance: • Major skeletal muscular injury • Crush injury • Burns
  • 21. 7. Lipid profile: 1. Total Cholesterol 2. Triglyceride 3. HDL-cholesterol ( High Density Lipoprotein ) 4. LDL-cholesterol ( Low Density Lipoprotein ) 5. VLDL-cholesterol ( Very Low Density Liporotein )
  • 22.  Cholesterol Principle:  Absorbance of quinoneimine dye is measured at 500nm. Method: • Enzymatic method
  • 23. Biological reference range:- Less than 199 mg /dL (Normal) 200 – 239 mg/dl (borderline) More than 240 mg/dl (high) Clinical significance : - Increase cholesterol suggestive of increase probability of following • Atherosclerosis • Coronary artery disease • Ischemic heart disease • Cerebro-Vascular Stroke • Hypertension • Xanthoma Decrease cholesterol suggestive of increase probability of following • Depression
  • 24.  Triglyceride Principle:  Absorption of quinoneimine dye (red color) is measured at 510nm. Method :  GPO – POD Method  End point method
  • 25. Biological reference range:- <150mg/dl Clinical significance: • 150 to 400 mg/dl is consider borderline hypertriglyceridemia. • More than 400 mg/dl only, increase risk of pancreatitis
  • 26. HDL , LDL , VLDL
  • 27.  HDL(High Density Lipoprotine) Principle:  Precipitates of all lipoprotein other than HDL (LDL & VLDL lipoproteins)  Precipitation done by  Dextran Sulfate  phosphotungsate acid  Polyethyl glycol  HDL left in the supernatant is tested using cholesterol assay. Method: Precipitation reaction
  • 28. Biological reference range :- 40-60 mg/dl HDL less than 40mg/dl means high risk of heart disease. Significance:  HDL transport cholesterol from peripheral tissues to liver by reverse cholesterol transport.  HDL also helps in the removal of macrophages from the arterial walls.
  • 29.  LDL(Low Density Lipoprotien) Principle:  Direct method: (selective precipitation)  Indirect method: (fridewald equation) LDL = [Total Cholesterol – HDL] – Plasma TG (mg/dl) 5
  • 30. Biological reference range:- 130-160 mg/dl LDL more than 160mg/dl means high risk of heart disease. Significance:  LDL tarnsport cholesterol from liver to peripheral cells.
  • 31.  VLDL(very low density lipoprotien) Friedewald’s equation: VLDL = Triglyceride/5 (mg/dl) Limitation : Can not useful in case of TG > 400 mg% Biological reference range:- 2-30 mg/dl
  • 32.
  • 34. DETERMINATION OF APOLIPOPROTIEN- A1 & B METHOD:- Turbidimetric immunoassays (TIA) PRINCIPLE:-  An insoluble TIA is formed by the reaction between the apo A-I antigen in human serum & the specific antibody in the antibody reagent. By using the activactor reagent,maximum exposure of antigenic sites achieved.  The turbidity is measured at 340nm.
  • 35. Biological reference range:-  Apolipoprotein A:-  More than 50mg/dl is desirable. Apolipoprotein B:-  less than 80mg/dl is desirable.